Cumulus Neuroscience, a leading innovator in brain health technology for clinical trials, today announced the publication of ...

It sounded exactly like her cousin. The tone, the urgency, even the familiar way he spoke. But the voice on the phone was not ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

Controlling light is an important technological challenge—not just at the large scale of optics in microscopes and telescopes ...

A new breakthrough study from the Rotman Research Institute at Baycrest, University of Toronto (Motsenyat et al., Brain Stimulation 2025) shows that brief sessions of pulsed photobiomodulation (PBM) ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...

Scientists have uncovered a way to manipulate the pathway in monkey brains that puts the brakes on motivation.

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...

All-optical image processing has been viewed as a promising technique for its high computation speed and low power ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

The Phase 1b trial consisted of 24 patients with Parkinson’s disease, who received twice-weekly dosing of either HER-096 or placebo over a four-week period. The trial’s exploratory biomarker program ...

Traditionally, power converter design for energy storage systems (BESS) normally focuses on conversion efficiency and total ...